Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Saturn Oil & Gas Inc. Announces its First Development of Cardium Wells at Brazeau and Continued Successful Development (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
9342-8530 Quebec Inc
DGCRF
Healthcare
Biotechnology
Diagnocure Inc is a Canada based biotechnology company. It is primarily engaged in the business activity of development and commercialization of products relating to the diagnosis of cancer. The group generates its revenue from research and license agreement. The head office of the company is located in Quebec, Canada.
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (GREY:DGCRF)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(5)
•••
RetailRube
X
View Profile
View Bullboard History
Comment by
RetailRube
on Jun 20, 2013 10:03am
RE: Stock Options Granted
For insider trades and options grants/cancellations, I use www.canadianinsider.com The official website run by the provincial securities commissions is more difficult to use but can do very powerful
...more
(5)
•••
RetailRube
X
View Profile
View Bullboard History
Post by
RetailRube
on Jun 19, 2013 3:12pm
Stock Options Granted
On June 11, 2013 the DiagnoCure Board of Directors granted 250,000 stock options to Herr Doktor Yves Fradet. Exercise price is 25.0 cents.
Xcyte Digital Corp. Signs Agreement to Purchase Assets of Webinar.net
posted May 02, 2024 9:00am by
Xcyte Digital Corp.
-
|
"The addition of Webinar.net further enhances Xcyte's suite of solutions by adding a technology platform that was built for and hosted on the cloud with enterprise grade scale and security. Webinar.net infrastructure is built to handle millions of online presentation attendees from global businesses. This acquisition further enhances our revenue and EBITDA growth in alignment with our medium-term expansion objectives ...read more
(5)
•••
RetailRube
X
View Profile
View Bullboard History
Post by
RetailRube
on Jun 19, 2013 3:12pm
Stock Options Granted
On June 11, 2013 the DiagnoCure Board of Directors granted 250,000 stock options to Herr Doktor Yves Fradet. Exercise price is 25.0 cents.
(5)
•••
RetailRube
X
View Profile
View Bullboard History
Post by
RetailRube
on Jun 19, 2013 3:12pm
Stock Options Granted
On June 11, 2013 the DiagnoCure Board of Directors granted 250,000 stock options to Herr Doktor Yves Fradet. Exercise price is 25.0 cents.
(228)
•••
Dibah42
X
View Profile
View Bullboard History
Post by
Dibah42
on Jun 03, 2013 4:23pm
HOLX dithering..?
"Because the concept that PCA3 can become a product of reference to help better diagnose prostate cancer patients is becoming more and more evident in the clinical community, we are in the midst
...more
(0)
•••
flyerca
X
View Profile
View Bullboard History
Post by
flyerca
on May 30, 2013 12:54am
Q2 June 3
DiagnoCure to host Q2 2013 earnings conference call and webcast DiagnoCure to host Q2 2013 earnings conference call and webcast QUEBEC CITY, May 28, 2013 /CNW Telbec
...more
(0)
•••
ready2go1
X
View Profile
View Bullboard History
Post by
ready2go1
on May 09, 2013 3:55pm
Pca3
Integrating New Therapies Into the Prostate Cancer Continuum Beth Fand Incollingo Published Online: Thursday, May 9, 2013 Attendees at the 6th
...more
(0)
•••
ready2go1
X
View Profile
View Bullboard History
Comment by
ready2go1
on May 08, 2013 12:49pm
RE: RE: Potential competition?
Two different tests; genomic test is from a biopsy to see how the cancer should be treated; pca3 test is a urine based test to determine how you should proceed after a negative biopsy. In many cases
...more
(0)
•••
Kondero
X
View Profile
View Bullboard History
Comment by
Kondero
on May 08, 2013 12:17pm
RE: Potential competition?
As you know for sure , Progensa can already do the same since a long time according to many scientific studies. The good news is that it may wake up Hologic. Fantomatus
(228)
•••
Dibah42
X
View Profile
View Bullboard History
Post by
Dibah42
on May 07, 2013 4:45pm
Potential competition?
INVESTORS MEDIA Physician Login Register for Updates Contact Us Share+ Company Science Oncotype DX® Pipeline Data
...more
(228)
•••
Dibah42
X
View Profile
View Bullboard History
Post by
Dibah42
on May 07, 2013 4:45pm
Potential competition?
INVESTORS MEDIA Physician Login Register for Updates Contact Us Share+ Company Science Oncotype DX® Pipeline Data
...more
(0)
•••
commeilfaut
X
View Profile
View Bullboard History
Comment by
commeilfaut
on May 03, 2013 9:54pm
RE: Pauvres actionnaires
arrette la drogue alex!!
(0)
•••
Alex1901
X
View Profile
View Bullboard History
Post by
Alex1901
on May 03, 2013 9:32pm
Pauvres actionnaires
Encore pris avec ce crétin de Fradet et sa gang d'incompétents
(0)
•••
Alex1901
X
View Profile
View Bullboard History
Post by
Alex1901
on May 03, 2013 9:32pm
Pauvres actionnaires
Encore pris avec ce crétin de Fradet et sa gang d'incompétents
(0)
•••
Keedan
X
View Profile
View Bullboard History
Comment by
Keedan
on Apr 30, 2013 2:46pm
RE: RE: RE: Assemblé des actionnaires AGM
Big volume??
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Mullen Group Ltd. Reports 2024 First Quarter Financial Results
Significant New Silver Discoveries in the Famous Keno Hill District in the Yukon
This Gambling Tech Stock is Future-Proofing the World’s Casinos and has No Direct Competition
Silvercorp to Acquire Adventus, Creating a Geographically Diversified Mining Company
Revolutionary Tech Company Announces Fourth Quarter and Full Year 2023 Results
Drill Permit Approval Received for New Mexico Lithium Project
This profitable gold stock is on its way up